About Index Trending news
Lists
Pricing
AnaptysBio

AnaptysBio

AnaptysBio

AnaptysBio is a biotechnology company developing novel therapeutic antibodies using its proprietary somatic hypermutation (SHM) technology

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
IPO
$75,000,000
Venture capital (Series B)
$33,000,000
Employees

Team size

10+
Locations
HQ
$75,000,000 IPO
Xconomy

AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut

Health Stock markets
Xconomy

Antibody Maker AnaptysBio Joins IPO Queue With $86M In Its Sights

Funding Health